Hypotheses and Evolution in the Current Treatment of Lipedema Syndrome

Pereira de Godoy JM, Guerreiro Godoy MdF
Journal of clinical medicine research · 24 fev 2022 · DOI 10.3390/cells9020430 · PMID 35317365

Abstract original

Este registro não tem abstract no PubMed. Consulte o artigo completo pelo link abaixo.

Ver no PubMed Artigo completo (DOI) Texto completo gratuito (PMC)

Mais em Epidemiologia e clínica

Estudo original Epidemiologia

Dual-Energy X-Ray absorptiometry based differentiation of lipoedema and familial partial lipodystrophy from general obesity in women

Lipoedema and familial partial lipodystrophy (FPLD) are rare adipose tissue disorders frequently misclassified as common obesity. Clinical assessment and body mass index (BMI) alone may fail to capture regional fat distribution,…

Avci F et al. · Endocrine · 29 out 2026

Estudo original Epidemiologia

Factors Associated with the Evolution in Quality of Life and Volume During the Maintenance Phase After a Multidisciplinary Intensive Treatment Program in Patients with Lower Limb Lymphedema

To evaluate which factors are associated with change in lymphedema-specific quality of life (QoL) and relative volume difference in the maintenance phase after a multidisciplinary intensive treatment program in patients with…

Heroes A et al. · Lymphatic research and biology · 22 out 2026

Estudo original Epidemiologia

Lipoedema in an adolescent male following valproate discontinuation: a case report

Sem abstract disponível no PubMed.

Kemer S et al. · Journal of rehabilitation medicine · 2 out 2026